AstraZeneca

News

Daiichi Sankyo partners Alteogen on subcutaneous Enhertu

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu.

News

AZ confirms China president has been detained

AstraZeneca has revealed that its top executive in China, Leon Wang, has been detained by Chinese authorities, after confirming he was under investigation last week.

News

AZ shares weaken as China investigation rumours swirl

AstraZeneca's shares have fallen more than 8% on speculation about an anti-corruption probe in China, its second-largest market, wiping around $14 billion off its value.

News

Pharmas ask appeals court to reconsider IRA lawsuits

The pharma industry's challenge to Medicare drug price negotiation powers continues to rumble on, with three drugmakers asking a US appeals court to revive their lawsuits.

News

AZ confirms its China president is under investigation

The head of AstraZeneca's Chinese operations has been placed under investigation by the authorities in Beijing, although the reasons for the probe remain unclear.

News

WhatsApp lands Moderna in hot water with PMCPA

A WhatsApp message has earned Moderna a reprimand from the UK's Prescription Medicines Code of Practice Authority (PMCPA), with Novo Nordisk, Otsuka, AstraZeneca, and Daiichi Sankyo also fo

Daiichi Sankyo partners Alteogen on subcutaneous Enhertu

AZ confirms China president has been detained

AZ shares weaken as China investigation rumours swirl

Pharmas ask appeals court to reconsider IRA lawsuits

AZ confirms its China president is under investigation

WhatsApp lands Moderna in hot water with PMCPA

Consolidating data strategy for global success: Insights fro...

How to meet your physicians where they are online

AstraZeneca

Editor's Picks